Keyphrases
Papillomavirus Infections
100%
Serum Immunoglobulin G
100%
HPV6
71%
High-risk Human Papillomavirus (HR-HPV)
71%
HPV16 Infection
57%
E Protein
33%
Human Papillomavirus 6
28%
Seropositivity
28%
Early childhood
28%
Infection Rate
28%
T Cells
28%
Type 6, 11, 16, 18
28%
Immunophenotypic Profile
28%
T Lymphocyte Subsets
28%
Genital
28%
Seroconversion
28%
Peripheral Blood
28%
Immune Response
14%
Persistency
14%
Second Pregnancy
14%
Maternal Antibodies
14%
Specific Intent
14%
Immunology
14%
Serology
14%
Cancer Development
14%
Horizontal Transmission
14%
Early Infancy
14%
Vertical Transmission
14%
E6 Protein
14%
Immune System
14%
L1 Protein
14%
Antibody Level
14%
E2 Protein
14%
Host Immune Response
14%
E7 Protein
14%
Mucosal Epithelium
14%
Early Protein
11%
Passive Immunization
11%
L Protein
11%
Immunology and Microbiology
Wart Virus
100%
Human Papillomavirus Type 6
58%
Human Papillomavirus Type 16
33%
Seropositivity
16%
Human Papillomavirus Type 11
16%
T Cell
16%
Human Papillomavirus Type 45
16%
T Lymphocyte Subpopulation
16%
Seroconversion
16%
L1 (Protein)
11%
Maternal Antibody
8%
Infancy
8%
Immune Response
8%
Serology
8%
Host Immune Response
8%
Immune System
8%
Immunology
8%
Offspring
8%
